Please provide your email address to receive an email when new articles are posted on . Proton pump inhibitors may be associated with pharmacovigilance signals for ...
The resistance of cancer cells to radiation therapy is a significant clinical problem in treating cancer. Many solid tumors are only partially responsive to radiation therapy, and increasing radiation ...
Proton Pump Inhibitors (PPIs) Market Worth USD 3.24 Billion, at 4% CAGR During 2019-2023 | Technavio
LONDON--(BUSINESS WIRE)--According to Technavio Research Report "Proton Pump Inhibitors (PPIs) Market by product (OTC PPIs and prescription PPIs) and geographical regions (North America, Europe, Asia ...
Please provide your email address to receive an email when new articles are posted on . An intervention program was associated with an absolute reduction of 7.3% in patients who filled proton pump ...
Nausea, heartburn, indigestion, upset stomach — anemia? Frequent sufferers of gastrointestinal symptoms may be doing more harm than good every time they reach for certain over-the-counter medications ...
Since their development and widespread adoption in the late 1980s, proton pump inhibitors (PPI) have transformed the field of gastroenterology. Their high efficacy and favorable safety profiles have ...
Hypomagnesemia increases the risk of chondrocalcinosis and calcium pyrophosphate disease. We examined whether the use of drugs that can cause hypomagnesemia, diuretics and proton pump inhibitors (PPIs ...
In a recent study published in Neurology, researchers determine whether the current and cumulative use of prescription proton pump inhibitors (PPIs) increases the risk of incident dementia. Study: ...
TOKYO, Jun 2, 2025 - (JCN Newswire) - - Eisai Co., Ltd. announced today the launch of "Pariet S" (pharmaceutical requiring guidance), which is highly effective in alleviating severe heartburn ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results